Legal News

ICSID—Canada prevails in $US 383m NAFTA case (Eli Lilly v Canada)

ICSID—Canada prevails in $US 383m NAFTA case (Eli Lilly v Canada)
Published on: 21 March 2017
Published by: Law360
  • ICSID—Canada prevails in $US 383m NAFTA case (Eli Lilly v Canada)
  • Original news
  • What did the tribunal decide?
  • What did the case concern?
  • Party representatives

Article summary

Arbitration analysis: Law360, New York: Canada has prevailed in a $CA 500m ($US 383m) investment treaty arbitration claim filed by US drugmaker Eli Lilly over the alleged wrongful termination of its drug patents. or take a trial to read the full analysis.

Popular documents